Alzheimer’s memory loss reversed by new head device using electromagnetic waves

There is finally some encouraging news for the millions of Americans suffering from Alzheimer’s Disease. NeuroEM Therapeutics today announced findings from an open-label clinical trial showing a reversal of cognitive impairment in Alzheimer’s Disease patients after just two months of treatment using the company’s wearable head device for in-home treatment.

Results demonstrate that TEMT was safe in all eight participating patients with mild to moderate AD and enhanced cognitive performance in seven of them, as measured by their ADAS-cog score, which is the benchmark for testing AD therapeutics. The study is being published in the new issue of the Journal of Alzheimer’s Disease.

Read more. 

Leave a Comment

Get one-month FREE access to our online yoga membership site.

Sign up to our mailing list to get one month free (Value $97)

We guard your privacy and will not sell/share your personal information.
We will contact you with information related of things of interest on an occasional basis.
To read our Privacy Policy Click here